Related Experiment Videos
Management of erectile dysfunction following radical prostatectomy
C D Zippe1, R Raina, M Thukral
1Andrology-Urology Research Laboratory, Urological Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, A100, Cleveland, OH 44195, USA. zippec@ccf.org
Current Urology Reports
|June 27, 2002
Summary
Radical prostatectomy causes significant erectile dysfunction, necessitating adjuvant therapies like injections or devices. Early penile rehabilitation is crucial for recovery and preventing fibrosis.
Area of Science:
- Urology
- Sexual Medicine
- Oncology
Background:
- Radical prostatectomy is standard for localized prostate cancer.
- Erectile dysfunction (ED) affects up to 90% of patients post-surgery.
- Current ED treatments have variable efficacy and poor long-term compliance.
Purpose of the Study:
- To review adjuvant treatments for post-prostatectomy erectile dysfunction.
- To discuss the role of penile rehabilitation and emerging oral therapies.
- To emphasize the importance of nerve-sparing surgical techniques.
Main Methods:
- Literature review of studies on post-prostatectomy ED treatments.
- Analysis of efficacy, compliance, and timing of interventions.
- Discussion of vacuum devices, intracavernosal injections, and oral medications.
Main Results:
- Non-oral ED treatments (devices, injections) show 50-70% response rates but nearly 50% one-year discontinuation.
- Early penile rehabilitation may prevent fibrosis and improve recovery.
- Oral sildenafil can aid erectile function return in select patients with nerve preservation.
Conclusions:
- Adjuvant ED therapies should be individualized, especially after oral medication failure.
- Early intervention with penile rehabilitation is recommended post-surgery.
- Advancements in oral therapies and nerve-sparing surgery offer improved outcomes for erectile function.